Their clinical-grade lentiviral gene therapy with erythroid-specific GATA1 expression improves erythropoiesis in DBA models and patient samples without affecting hematopoietic stem cell function (24). The gene discussed is GATA1; the disease is Diamond-Blackfan anemia.